10 Firms To Steer 8 IPOs Exceeding $2B As October Stays Hot

Law360 (October 19, 2020, 9:03 PM EDT) -- A life sciences research company and an oncology firm set price ranges for initial public offerings on Monday, joining a busy lineup of eight IPO prospects set to go public this week and potentially raise $2.3 billion combined, guided by 10 law firms total.

Abcam plc, which makes research tools for the life sciences industry, expects to raise about $148 million, while cancer drug developer Foghorn Therapeutics Inc. unveiled plans to raise about $128 million, according to U.S. Securities and Exchange Commission filings on Monday.

Both offerings are set before the end of the week, according to IPO research firm Renaissance...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!